GHRS
Gh Research Plc Health Care Pharmaceutical Preparations Russell 3000
$20.86Close
$12.48 – $30.6452-week range
Nov 5, 2026Next report
Highlights
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Far from its high 32% below its 52-week high
- Distribution down-day volume 1.6× up-day volume over 50 sessions
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
5.7%
$1.19 a day · 2×ATR $18.48
RS
56 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
0.63
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: fails
Screen verdict
Not scorable — no classified balance sheet.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Mar 5, 2026 | Annual ↗ | — | 0d |
| Feb 27, 2025 | Annual ↗ | — | 0d |
| Mar 7, 2024 | Annual ↗ | — | 0d |
| Mar 9, 2023 | Annual ↗ | — | 0d |
| Mar 28, 2022 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 9, 2026 | Foreign issuer report ↗ |
| Sep 11, 2026 | Foreign issuer report ↗ |
| Aug 6, 2026 | Foreign issuer report ↗ |
| Jun 26, 2026 | Foreign issuer report ↗ |
| Jun 4, 2026 | Foreign issuer report ↗ |
| May 21, 2026 | Foreign issuer report ↗ |
| May 14, 2026 | Foreign issuer report ↗ |
| May 14, 2026 | Foreign issuer report ↗ |
| May 13, 2026 | Foreign issuer report ↗ |
| May 13, 2026 | Foreign issuer report ↗ |
| Apr 30, 2026 | Foreign issuer report ↗ |
| Mar 25, 2026 | Foreign issuer report ↗ |